DOCSLIB.ORG

Supplementary Table 3: Calcineurin- and Aging-Sensitive Genes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 3: Calcineurin- and Aging-Sensitive Genes Supplementary Table 3: Calcineurin- and Aging-Sensitive Genes Supplementary Table 3: Calcineurin up/ Aging up (pages 1 -2)- genes classified as Ad-aCaN up in the present study (see Supplementary Table 1), as well as reported as significantly increased in our prior aging study (Blalock et al., 2003, see supplementary tables 3, 4 and 5). Calcineurin Down/ Aging Down (page 2), Calcineurin Up/ Aging Down (pages 2-3),and Calcineurin Down/Aging Up (page 3)as above except for direction of change. - Columns: Probe Set- Affymetrix probe set identifier for RG-U34A microarray, Symbol and Title- annotated information for above probe set (annotation downloaded June, 2004), Calcineurin ANOVA- p-value for 1-way Analysis of Variance. Calcineurin Up/Aging Up Probe set Symbol Title CaN ANOVA rc_AI170268_at B2m beta-2 microglobulin 0.00000 rc_AI102299_s_at Bid3 BH3 interacting domain 3 0.00721 X52477_at C3 complement component 3 0.00000 X58294_at Ca2 carbonic anhydrase 2 0.00004 X76489cds_g_at Cd9 CD9 antigen 0.00000 L07736_at Cpt1a carnitine palmitoyltransferase 1, liver 0.00001 M55534mRNA_s_at Cryab crystallin, alpha B 0.00000 X60351cds_s_at Cryab crystallin, alpha B 0.00000 rc_AI234146_at Csrp1 cysteine and glycine-rich protein 1 0.00000 rc_AI176595_s_at Ctsl cathepsin L 0.00001 D00569_at Decr1 2,4-dienoyl CoA reductase 1, mitochondrial 0.00000 rc_AA924925_at Dri42 ER transmembrane protein Dri 42 0.00000 rc_AA848831_at Edg2 endothelial differentiation, lysophosphatidic acid GPCR, 2 0.00000 X14323cds_g_at Fcgrt Fc receptor, IgG, alpha chain transporter 0.00000 L00191cds#1_s_at Fn1 fibronectin 1 0.00013 rc_AI231807_at Ftl1 ferritin light chain 1 0.00000 rc_AI231807_g_at Ftl1 ferritin light chain 1 0.00000 rc_AA799645_at Fxyd1 FXYD domain-containing ion transport regulator 1 0.00031 rc_AA799645_g_at Fxyd1 FXYD domain-containing ion transport regulator 1 0.00000 U92081mRNA_s_at Gp38 glycoprotein 38 0.00399 X62322_g_at Grn granulin 0.00000 X78848cds_f_at Gsta1 glutathione S-transferase, alpha 1 0.00000 rc_AI012589_s_at Gstp2 glutathione S-transferase, pi 2 0.00001 X02904cds_s_at Gstp2 glutathione S-transferase, pi 2 0.00007 AF008554_at IAG2 implantation-associated protein 0.00007 rc_AI231213_g_at Kai1 kangai 1 0.00000 D90211_s_at Lamp2 lysosomal membrane glycoprotein 2 0.00004 M32016_at Lamp2 lysosomal membrane glycoprotein 2 0.00012 X54096_at Lcat lecithin cholesterol acyltransferase 0.00000 rc_AI237535_s_at Litaf LPS-induced TNF-alpha factor 0.00009 M23601_at Maob monoamine oxidase B 0.00066 J03752_at Mgst1 microsomal glutathione S-transferase 1 0.00002 U10357_g_at Pdk2 pyruvate dehydrogenase kinase 2 0.00002 AB000778_s_at Pld1 phospholipase D1 0.00000 S55427_s_at Pmp22 peripheral myelin protein 22 0.00000 Y17295cds_s_at Prdx6 peroxiredoxin 6 0.00000 M19936_at Psap prosaposin 0.02210 L40362_f_at RT1-Aw2 RT1 class Ib, locus Aw2 0.00000 M24026_f_at RT1-Aw2 RT1 class Ib, locus Aw2 0.00000 M11071_f_at RT1-Aw2 RT1 class Ib, locus Aw2 0.00037 M31018_f_at RT1-Aw2 RT1 class Ib, locus Aw2 0.00000 M24324_f_at RT1-Aw2 RT1 class Ib, locus Aw2 0.00001 X06916_at S100a4 S100 calcium-binding protein A4 0.00000 S53527mRNA_s_at S100b S100 protein, beta polypeptide 0.00000 S61868_g_at Sdc4 syndecan 4 0.02260 U37138_at Sts steroid sulfatase 0.00108 D38380_at Tf Transferrin 0.00000 D38380_g_at Tf Transferrin 0.00000 X62952_at Vim vimentin 0.00000 Page 1 Supplementary Table 3: Calcineurin- and Aging-Sensitive Genes Probe set Symbol Title CaN ANOVA Calcineurin Down/Aging Down rc_AA942685_at Cdo1 cytosolic cysteine dioxygenase 1 0.00705 U66470_at Cgref1 cell growth regulator with EF hand domain 1 0.00002 rc_AA892506_at Coro1a coronin, actin binding protein 1A 0.00001 D89340_at Dpp3 dipeptidylpeptidase III 0.03376 AF023087_s_at Egr1 early growth response 1 0.00001 U78102_at Egr2 early growth response 2 0.00014 rc_AI230914_at Fntb farnesyltransferase beta subunit 0.00001 L21192_at Gap43 growth associated protein 43 0.01584 rc_AA799779_g_at Gnpat acyl-CoA:dihydroxyacetonephosphate acyltransferase 0.00012 D37951UTR#1_at Hivep2 human immunodeficiency virus type 1 enhancer-binding protein 2 0.00000 X54793_at Hsp60 heat shock protein 60 (liver) 0.02154 M24852_at Pcp4 Purkinje cell protein 4 0.00029 AB020504_at Pmf31 PMF32 protein 0.04777 U06099_at Prdx2 peroxiredoxin 2 0.02349 AA799389_at Rab3b Rab3B protein 0.00578 X78605_at Rab4b ras-related GTP-binding protein 4b 0.00186 L46873_s_at Slc15a1 solute carrier family 15 (oligopeptide transporter), member 1 0.00928 K02248cds_s_at Sst somatostatin 0.00000 M93273_at Sstr2 somatostatin receptor 2 0.00001 L42855_at TCEB2 transcription elongation factor B (SIII) polypeptide 2 (18kD, elongin B) 0.01315 M31174_at Thra thyroid hormone receptor alpha 0.03833 D10699_g_at Uchl1 ubiquitin carboxy-terminal hydrolase L1 0.00651 Calcineurin Up/Aging Down U89905_at Amacr alpha-methylacyl-CoA racemase 0.04540 AF087037_at Btg3 B-cell translocation gene 3 0.00118 M27207mRNA_s_at Col1a1 collagen, type 1, alpha 1 0.00195 U75405UTR#1_f_at Col1a1 collagen, type 1, alpha 1 0.01215 M21354_s_at Col3a1 collagen, type III, alpha 1 0.00080 U90610_g_at Cxcr4 Chemokine receptor (LCR1) 0.00000 J02773_at Fabp3 fatty acid binding protein 3 0.02837 rc_AI237731_s_at Lpl lipoprotein lipase 0.00766 X84039_at Lum lumican 0.00035 X76985_at Lxn latexin 0.00000 M83745_at Pcsk2 proprotein convertase subtilisin/kexin type 2 0.03212 U28938_at Ptpro protein tyrosine phosphatase, receptor type, O 0.00111 X98399cds_s_at Slc14a1 solute carrier family 14, member 1 0.00695 M15191_s_at Tac1 tachykinin 1 0.00000 rc_AI136891_at Zfp36l1 zinc finger protein 36, C3H type-like 1 0.00015 Calcineurin Down/Aging Up M77245_at Ap1b1 adaptor protein complex AP-1, beta 1 subunit 0.00022 U67137_at Dlgap1 guanylate kinase associated protein 0.00621 rc_AA892775_at Lyz lysozyme 0.00007 Page 2.
Load more

Recommended publications
  • The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z
    REVIEW pubs.acs.org/CR The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z. Long* and Benjamin F. Cravatt* The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States CONTENTS 2.4. Other Phospholipases 6034 1. Introduction 6023 2.4.1. LIPG (Endothelial Lipase) 6034 2. Small-Molecule Hydrolases 6023 2.4.2. PLA1A (Phosphatidylserine-Specific 2.1. Intracellular Neutral Lipases 6023 PLA1) 6035 2.1.1. LIPE (Hormone-Sensitive Lipase) 6024 2.4.3. LIPH and LIPI (Phosphatidic Acid-Specific 2.1.2. PNPLA2 (Adipose Triglyceride Lipase) 6024 PLA1R and β) 6035 2.1.3. MGLL (Monoacylglycerol Lipase) 6025 2.4.4. PLB1 (Phospholipase B) 6035 2.1.4. DAGLA and DAGLB (Diacylglycerol Lipase 2.4.5. DDHD1 and DDHD2 (DDHD Domain R and β) 6026 Containing 1 and 2) 6035 2.1.5. CES3 (Carboxylesterase 3) 6026 2.4.6. ABHD4 (Alpha/Beta Hydrolase Domain 2.1.6. AADACL1 (Arylacetamide Deacetylase-like 1) 6026 Containing 4) 6036 2.1.7. ABHD6 (Alpha/Beta Hydrolase Domain 2.5. Small-Molecule Amidases 6036 Containing 6) 6027 2.5.1. FAAH and FAAH2 (Fatty Acid Amide 2.1.8. ABHD12 (Alpha/Beta Hydrolase Domain Hydrolase and FAAH2) 6036 Containing 12) 6027 2.5.2. AFMID (Arylformamidase) 6037 2.2. Extracellular Neutral Lipases 6027 2.6. Acyl-CoA Hydrolases 6037 2.2.1. PNLIP (Pancreatic Lipase) 6028 2.6.1. FASN (Fatty Acid Synthase) 6037 2.2.2. PNLIPRP1 and PNLIPR2 (Pancreatic 2.6.2.
    [Show full text]
  • PDE6) by the Glutamic Acid- Rich Protein-2 (GARP2)
    University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Fall 2013 Regulation of the catalytic and allosteric properties of photoreceptor phosphodiesterase (PDE6) by the glutamic acid- rich protein-2 (GARP2) Wei Yao Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation Yao, Wei, "Regulation of the catalytic and allosteric properties of photoreceptor phosphodiesterase (PDE6) by the glutamic acid-rich protein-2 (GARP2)" (2013). Doctoral Dissertations. 747. https://scholars.unh.edu/dissertation/747 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. REGULATION OF THE CATALYTIC AND ALLOSTERIC PROPERTIES OF PHOTORECEPTOR PHOSPHODIESTERASE (PDE6) BY THE GLUTAMIC ACID-RICH PROTEIN-2 (GARP2) BY WEI YAO B.S., Jinan University, 2007 DISSERTATION Submitted to the University of New Hampshire in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Biochemistry September, 2013 UMI Number: 3575987 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Di!ss0?t&iori Piiblist’Mlg UMI 3575987 Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
    [Show full text]
  • Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights Since 2016
    International Journal of Molecular Sciences Review Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016 Susann Schröder 1,2,* , Matthias Scheunemann 2, Barbara Wenzel 2 and Peter Brust 2 1 Department of Research and Development, ROTOP Pharmaka Ltd., 01328 Dresden, Germany 2 Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 04318 Leipzig, Germany; [email protected] (M.S.); [email protected] (B.W.); [email protected] (P.B.) * Correspondence: [email protected]; Tel.: +49-341-234-179-4631 Abstract: Cyclic nucleotide phosphodiesterases (PDEs) represent one of the key targets in the research field of intracellular signaling related to the second messenger molecules cyclic adenosine monophosphate (cAMP) and/or cyclic guanosine monophosphate (cGMP). Hence, non-invasive imaging of this enzyme class by positron emission tomography (PET) using appropriate isoform- selective PDE radioligands is gaining importance. This methodology enables the in vivo diagnosis and staging of numerous diseases associated with altered PDE density or activity in the periphery and the central nervous system as well as the translational evaluation of novel PDE inhibitors as therapeutics. In this follow-up review, we summarize the efforts in the development of novel PDE radioligands and highlight (pre-)clinical insights from PET studies using already known PDE Citation: Schröder, S.; Scheunemann, radioligands since 2016. M.; Wenzel, B.; Brust, P. Challenges on Cyclic Nucleotide Keywords: positron emission tomography; cyclic nucleotide phosphodiesterases; PDE inhibitors; Phosphodiesterases Imaging with PDE radioligands; radiochemistry; imaging; recent (pre-)clinical insights Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016.
    [Show full text]
  • Modulation of the Camp Levels with a Conserved Actinobacteria Phosphodiesterase 2 Enzyme Reduces Antimicrobial Tolerance in Mycobacteria
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.26.267864; this version posted August 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Modulation of the cAMP levels with a conserved actinobacteria phosphodiesterase 2 enzyme reduces antimicrobial tolerance in mycobacteria 3 4 Michael Thomson1, Kanokkan Nunta1, Ashleigh Cheyne1, Yi liu1, Acely Garza-Garcia2 and 5 Gerald Larrouy-Maumus1† 6 7 1MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, 8 Faculty of Natural Sciences, Imperial College London, London, SW7 2AZ, UK 9 2The Francis Crick Institute, London NW1 1AT, United Kingdom. 10 11 †Corresponding author: 12 13 Dr Gerald Larrouy-Maumus 14 MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Faculty 15 of Natural Sciences, Imperial College London, London, SW7 2AZ, UK 16 Telephone: +44 (0) 2075 947463 17 E-mail: [email protected] 18 19 20 1 e ag P 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.26.267864; this version posted August 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 21 Abstract 22 Antimicrobial tolerance (AMT) is the gateway to the development of antimicrobial resistance 23 (AMR) and is therefore a major issue that needs to be addressed. 24 The second messenger cyclic-AMP (cAMP), which is conserved across all taxa, is involved 25 in propagating signals from environmental stimuli and converting these into a response.
    [Show full text]
  • Development of Phosphodiesterase-Protein Kinase Complexes As Novel Targets for Discovery of Inhibitors with Enhanced Spec- Ificity
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 6 April 2021 doi:10.20944/preprints202104.0174.v1 Article Development of Phosphodiesterase-Protein Kinase complexes as novel targets for discovery of inhibitors with enhanced spec- ificity Nikhil K. Tulsian 1,2, Valerie Jia-En Sin 3, Hwee-Ling Koh 3,*, Ganesh S. Anand 1,4,* 1 Department of Biological Sciences, 14 Science Drive 4, National University of Singapore, Singapore – 117543 2 Department of Biochemistry, 28 Medical Drive, National University of Singapore, Singapore – 117546 3 Department of Pharmacy, 18 Science Drive 4, National University of Singapore, Singapore – 117543 4 Department of Chemistry, The Pennsylvania State University, Philadelphia, United States of America - 16801 * Correspondence: KHL: [email protected]; Tel.: +6565167962; GSA: [email protected]; Tel.: 814-867-1944 Abstract: Phosphodiesterases (PDEs) hydrolyze cyclic nucleotides to modulate multiple signaling events in cells. PDEs are recognized to actively associate with cyclic nucleotide receptors (Protein Kinases, PK) in larger macromolecular assemblies referred to as signalosomes. Complexation of PDEs with PK generates an expanded active site which enhances PDE activity. This facilitates signal- osome-associated PDEs to preferentially catalyze active hydrolysis of cyclic nucleotides bound to PK, and aid in signal termination. PDEs are important drug targets and current strategies for inhib- itor discovery are based entirely on targeting conserved PDE catalytic domains. This often results in inhibitors with cross-reactivity amongst closely related PDEs and attendant unwanted side ef- fects. Here, our approach targets PDE-PK complexes as they would occur in signalosomes, thereby offering greater specificity. Our developed fluorescence polarization assay has been adapted to identify inhibitors that block cyclic nucleotide pockets in PDE-PK complexes in one mode, and dis- rupt protein-protein interactions between PDEs and cyclic nucleotide activating protein kinases in a second mode.
    [Show full text]
  • Soluble Epoxide Hydrolase Inhibition Protected Against Angiotensin II
    www.nature.com/scientificreports OPEN Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Received: 6 April 2017 Accepted: 29 June 2017 Remodeling Published online: 31 July 2017 Chi Zhou, Jin Huang, Qing Li, Jiali Nie, Xizhen Xu & Dao Wen Wang Epoxyeicosatrienoic acids (EETs), the metabolites of cytochrome P450 epoxygenases derived from arachidonic acid, exert important biological activities in maintaining cardiovascular homeostasis. Soluble epoxide hydrolase (sEH) hydrolyzes EETs to less biologically active dihydroxyeicosatrienoic acids. However, the efects of sEH inhibition on adventitial remodeling remain inconclusive. In this study, the adventitial remodeling model was established by continuous Ang II infusion for 2 weeks in C57BL/6 J mice, before which sEH inhibitor 1-trifuoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) was administered by gavage. Adventitial remodeling was evaluated by histological analysis, western blot, immunofuorescent staining, calcium imaging, CCK-8 and transwell assay. Results showed that Ang II infusion signifcantly induced vessel wall thickening, collagen deposition, and overexpression of α-SMA and PCNA in aortic adventitia, respectively. Interestingly, these injuries were attenuated by TPPU administration. Additionally, TPPU pretreatment overtly prevented Ang II-induced primary adventitial fbroblasts activation, characterized by diferentiation, proliferation, migration, and collagen synthesis via Ca2+-calcineurin/NFATc3 signaling pathway in vitro. In summary, our results suggest that inhibition of sEH could be considered as a novel therapeutic strategy to treat adventitial remodeling related disorders. Aorta is composed of three tunicae: intima, media and adventitia. Te roles of intima and media on vascular functions have been extensively studied, while the contribution of adventitia to vascular functions was recently recognized.
    [Show full text]
  • Phosphodiesterase Type 5 Inhibitors: a Biochemical and Clinical Correlation Survey
    International Journal of Impotence Research (2003) 15, Suppl 5, S13–S19 & 2003 Nature Publishing Group All rights reserved 0955-9930/03 $25.00 www.nature.com/ijir Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey NN Kim1* 1Department of Urology, Institute for Sexual Medicine, Boston University School of Medicine, Boston, Massachusetts, USA Phosphodiesterase type 5 (PDE 5) is the major cGMP hydrolyzing enzyme in penile corpus cavernosum and is an important regulator of nitric oxide-mediated smooth muscle relaxation. The critical role of PDE 5 in penile erection and the recent availability of specific and potent inhibitors of PDE 5 have enabled the development of effective oral treatment strategies that have been widely accepted by both health-care professionals and the lay public. This article examines the correlation between the available biochemical and clinical data for the PDE 5 inhibitors sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra). International Journal of Impotence Research (2003) 15, Suppl 5, S13–S19. doi:10.1038/sj.ijir.3901067 Keywords: phosphodiesterase type 5 inhibitor; sildenafil; tadalafil; vardenafil; Viagra; Cialis; Levitra; potency; efficacy; safety Introduction differing substrate specificities based upon their ability to discriminate between cGMP and adeno- sine 30,50-cyclic monophosphate (cAMP). Further- Guanosine 30,50-cyclic monophosphate (cGMP) is an more, the activity of different phosphodiesterases important mediator of smooth muscle relaxation and may be modulated by varying mechanisms. Thus, has been shown to be a key molecular regulator of regulation of cyclic nucleotide metabolism depends penile tumescence. Intracellular cGMP concentra- on the specific expression profile of the various tions are strictly controlled by the action of guanylyl phosphodiesterase types in a given tissue.
    [Show full text]
  • Activx Serine Hydrolase Probes
    INSTRUCTIONS ® ActivX Serine Hydrolase Probes 2347.0 88316 88317 88318 Number Description 88316 ActivX Azido-FP Serine Hydrolase Probe, 3.5µg Molecular Weight: 350.37 88317 ActivX Desthiobiotin-FP Serine Hydrolase Probe, 4.6µg Molecular Weight: 463.57 88318 ActivX TAMRA-FP Serine Hydrolase Probe, 6.8µg Molecular Weight: 679.76 Storage: Upon receipt store at -80°C. Product shipped with dry ice. Contents Introduction ................................................................................................................................................................................. 1 Procedure Summary ..................................................................................................................................................................... 2 Important Product Information .................................................................................................................................................... 2 Procedure for Protein Labeling and Detection ............................................................................................................................. 3 Procedure for Protein Labeling and Enrichment .......................................................................................................................... 4 Procedure for Active-Site Peptide Enrichment ............................................................................................................................ 5 Troubleshooting ..........................................................................................................................................................................
    [Show full text]
  • Of Hypertensive Rats
    Proc. Nat. Acad. Sci. USA Vol. 71, No. 12, pp. 4930-4934, December 1974 Aberrations of Cyclic Nucleotide Metabolism in the Hearts and Vessels of Hypertensive Rats (spontaneous hypertension/stress hypertension/desoxycorticosterone acetate hypertension/ nucleotide cyclases/cyclic nucleotide phosphodiesterase) M. SAMIR AMER, ALLEN W. GOMOLL, JAMES L. PERHACH, JR., HUGH C. FERGUSON, AND GORDON R. McKINNEY Department of Pharmacology, Mead Johnson Research Center, Evansville, Indiana 47721 Communicated by Bernard B. Brodie, September 26, 1974 ABSTRACT In the aortas and mesenteric arteries from hypertensive rats were prepared as described by Stanton and spontaneous hypertensive rats and in the aortas from White (6). Systolic blood pressures were determined indirectly stress- and desoxycorticosterone-acetate-hypertensive ± + 4, and rats, the intracellular cGMP: cAMP ratios were signifi- by the tail cuff technique and were 192 3, 165 cantly elevated when compared to the ratios in the aortas 226 + 1 mm Hg for the spontaneous, stress, and DOCA-hyper- of the respective controls. Decreases in the intracellular tensive rats, respectively. Control rats for those same groups cAMP or cGMP levels were consistently associated with had pressures of 130 + 2, 125 A 2, and 132 4 2 mm Hg, increased activity of the cyclic-nucleotide-specific low Km respectively. Values are i SEM. phosphodiesterase (3':5'.-cAMP 5' nucleotidohydrolase, EC 3.1.4.17). Increases in intracellular cGMP levels were Most of the experiments were carried out on the aortas, associated with elevated guanylyl cyclase [GTP pyrophos- mesenteric arteries, and hearts removed from the animals im- phate-lyase (cyclizing), EC 4.6.1.2] activity. Furthermore, mediately after their decapitation.
    [Show full text]
  • Phospholipases in Bacterial Virulence and Pathogenesis
    Review Article Adv Biotech & Micro Volume 10 Issue 5 - September 2018 Copyright © All rights are reserved by Kaur Jagdeep DOI: 10.19080/AIBM.2018.10.555798 Phospholipases in Bacterial Virulence and Pathogenesis Kumari Bandana, Kaur Jashandeep and Kaur Jagdeep* Department of Biotechnology, Panjab University, India Submission: June14, 2018; Published: September 04, 2018 *Corresponding author: Jagdeep Kaur, Professor, Department of Biotechnology, BMS Block-1, South Campus, Panjab University, Chandigarh 160014, India, Tel: (o)0172-2534085, Fax: + 91-172-2541409; Email; Abstract Phospholipases are ubiquitous hydrolases that catalyze the hydrolysis of phospholipids, a key component of eukaryotic cellular membranes. The metabolites generated after hydrolysis functions as secondary messengers that are further involved in signal transduction, membrane number of ways like host cell invasion, modulating the phospholipid content of their membrane, and so on. Also, these enzymes are crucial for the pathogenesistrafficking, cell of proliferation,certain bacteria etc. because These enzymesof their role are in considered escape from as the an hostimportant defence virulence mechanism. factors, This as review they help is focused the bacterial on different pathogens diversity in of PLs and their role in pathogenesis and virulence in bacterial infection. Keywords: Phospholipase; Virulence; Pathogenesis; Host cell invasion; Lipid droplet; Phosphatidylcholine; Drug target Abbreviations: PLA: Phospholipase A; PLB: Phospholipases B; PLD: Phospholipase D; SAM: Sterile Alfa Motif; SG: Src Homology; PMN: Polymorphonuclear Cells Introduction Infectious diseases are caused by bacteria, fungi, viruses, Phospholipids and phospholipases or parasites. These may be communicable, acquired from Phospholipids are the key component of cellular membrane contaminated food or water, or may spread by insect bites, etc.
    [Show full text]
  • The Role of Phosphatidylinositol-Specific Phospholipase-C in Plant Defense Signaling
    The Role of Phosphatidylinositol-Specific Phospholipase-C in Plant Defense Signaling Ahmed M. Abd-El-Haliem Thesis committee Promotor Prof. Dr P.J.G.M. de Wit Professor of Phytopathology Wageningen University Co-promotor Dr M.H.A.J. Joosten Associate professor, Laboratory of Phytopathology Wageningen University Other members Prof. Dr H.J. Bouwmeester, Wageningen University Prof. Dr M.W. Prins, University of Amsterdam Prof. Dr G.C. Angenent, Wageningen University Dr S.H.E.J. Gabriёls, Monsanto Holland BV, Wageningen This research was conducted under the auspices of the Graduate School of Experimental Plant Sciences. The Role of Phosphatidylinositol-Specific Phospholipase-C in Plant Defense Signaling Ahmed M. Abd-El-Haliem Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Thursday 23 October 2014 at 11.00 a.m. in the Aula. Ahmed M. Abd-El-Haliem The Role of Phosphatidylinositol-Specific Phospholipase-C in Plant Defense Signaling, 188 pages. PhD thesis, Wageningen University, Wageningen, NL (2014) With references, with summaries in Dutch and English ISBN 978-94-6257-118-1 TABLE OF CONTENTS CHAPTER 1 General Introduction & Thesis Outline 7 CHAPTER 2 Identification of Tomato Phosphatidylinositol-Specific 19 Phospholipase-C (PI-PLC) Family Members and the Role of PLC4 and PLC6 in HR and Disease Resistance CHAPTER 3 Defense Activation
    [Show full text]
  • Analyses of PDE-Regulated Phosphoproteomes Reveal Unique
    Analyses of PDE-regulated phosphoproteomes reveal PNAS PLUS unique and specific cAMP-signaling modules in T cells Michael-Claude G. Beltejara, Ho-Tak Laua, Martin G. Golkowskia, Shao-En Onga, and Joseph A. Beavoa,1 aDepartment of Pharmacology, University of Washington, Seattle, WA 98195 Contributed by Joseph A. Beavo, May 28, 2017 (sent for review March 10, 2017; reviewed by Paul M. Epstein, Donald H. Maurice, and Kjetil Tasken) Specific functions for different cyclic nucleotide phosphodiester- to bias T-helper polarization toward Th2, Treg, or Th17 pheno- ases (PDEs) have not yet been identified in most cell types. types (13, 14). In a few cases increased cAMP may even potentiate Conventional approaches to study PDE function typically rely on the T-cell activation signal (15), particularly at early stages of measurements of global cAMP, general increases in cAMP- activation. Recent MS-based proteomic studies have been useful dependent protein kinase (PKA), or the activity of exchange in characterizing changes in the phosphoproteome of T cells under protein activated by cAMP (EPAC). Although newer approaches various stimuli such as T-cell receptor stimulation (16), prosta- using subcellularly targeted FRET reporter sensors have helped glandin signaling (17), and oxidative stress (18), so much of the define more compartmentalized regulation of cAMP, PKA, and total Jurkat phosphoproteome is known. Until now, however, no EPAC, they have limited ability to link this regulation to down- information on the regulation of phosphopeptides by PDEs has stream effector molecules and biological functions. To address this been available in these cells. problem, we have begun to use an unbiased mass spectrometry- Inhibitors of cAMP PDEs are useful tools to study PKA/EPAC- based approach coupled with treatment using PDE isozyme- mediated signaling, and selective inhibitors for each of the 11 PDE – selective inhibitors to characterize the phosphoproteomes of the families have been developed (19 21).
    [Show full text]